Scholarly and Professional Work 

Refereed Publications (Trainees Underlined)

  1. Bubela T, Cook-Deegan R (in press, 2015) Defending Access to Research Tools: Keeping Score, Strengthening Policy, and Fighting Bad Actors. Nature Biotechnology. [IF 39.1]
  2. Bubela T, Guebert J, Mishra A (in press, 2015) Use and Misuse of Material Transfer Agreements: Lessons from Research, Repositories, and Litigation. PLoS Biology. [IF 12.690]
  3. Bubela T, Vishnubhakat S, Cook-Deegan R (under review, 2015) The Mouse that Trolled: The Long and Tortuous History of a Gene Mutation Patent that Became and Expensive Impediment to Alzheimer’s Research. Journal of Law and the Biosciences.
  4. McGetrick JA, Bubela T, Hik DS (under review, 2015) A Different Way of Being Consulted”: Circumpolar Perspectives on Indigenous Communities’ Use of Geographic Information Systems to Communicate the Health Impacts of Development. Global Environmental Change. [IF 6.87]
  5. Luth W, Bubela T (under review, 2015) Playing with Food: Adolescent experiences of food and beverages in video games. Journal of Adolescent Research. [IF 1.218]
  6. Mishra A, Schofield PN, Bubela T (under review, 2015) Sustaining large-scale infrastructure to promote pre-competitive biomedical research: Lessons from mouse genomics. New Biotechnology. [IF 2.499]
  7. Kowal S, Bubela T, Jardine C (revisions requested, 2015) “If they tell me to get it, I’ll get it. If they don’t….”: Immunization Decision-Making Processes of Immigrant Mothers. Canadian Journal of Public Health. [IF 1.325]
  8. Kowal S, Jardine C, Bubela T (revisions requested, 2015) Paternalism, Autonomy, and Public Health Goals: Meaningful informed consent for immunization by immigrant women. Public Health Ethics.
  9. Bubela T, McCabe C (2014) Value-Engineered Translation: Developing Biotherapeutics that align with health-system needs. American Journal of Managed Care: Evidence-Based Diabetes Management 20 (Special Issue 10): SP307-SP312.
  10. Schindel DE, Bubela T, Rosenthal J, Castle D, du Plessis P, Bye R (under review, 2015) Non-Commercial Research, Access to Biological Samples, and the Equitable Sharing of Benefits: A Case Study of DNA Barcoding and Medicinal Plants. Nature Conservation. [New Journal]
  11. Guebert J, Bubela T (2014) Implementing Socially Responsible Licensing for Global Health: Beyond Neglected Diseases. Science Translational Medicine 6: 260Cm11 [IF 10.575]
  12.  Mishra A, Bubela T (2014) Legal Agreements and the Governance of Research Commons: Lessons from Materials Sharing in Mouse Genomics. Omics A Journal of Integrative Biology 18(4): 254-273.  [IF 2.730; PMID 24552652] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976585/
  13. Benjaminy S, Bubela T (2014) Ocular Gene Transfer in the Spotlight: Implications of Newspaper Content for Clinical Communications. BMC Medical Ethics. [IF 1.705] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107594/
  14. Li MD, Atkins, HL, Bubela T (in press, 2013) The Global Landscape of Stem Cell Clinical Trials. Regenerative Medicine. [IF 3.873]  http://www.futuremedicine.com/doi/full/10.2217/rme.13.80
  15. Bubela T, McCabe C (2014) Value-Engineered Translation for Regenerative Medicine: Meeting the Needs of Health Systems. Stem Cells and Development. [Impact Factor 4.670]  http://online.liebertpub.com/doi/full/10.1089/scd.2013.0398
  16. Caulfield T, Evans J, McGuire A, McCabe C, Bubela T, Cook-Deegan R, Fishman J, Hogarth S, Miller FA, Ravitsky V, et al.  (in press, 2013) Reflections on the Cost of “Low-Cost” Whole Genome Sequencing: Framing the Health Policy Debate. PLoS Biology. [IF 12.690]  http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001699
  17. Benjaminy S, MacDonald I, Bubela T (2013) “Is a Cure in My Sight?” Multi-Stakeholder Perspectives on Phase-I Choroideremia Gene Transfer Clinical Trials. Genetics in Medicine doi:10.1038/gim.2013.148. [IF 5.560; PMID: 24071795]  http://www.nature.com/gim/journal/v16/n5/full/gim2013148a.html
  18. Geary J, Jardine C, Guebert J, Bubela T. Access and Benefits Sharing of Genetic Resources and Associated Traditional Knowledge in Northern Canada: Understanding the Legal Environment and Creating Effective Research Agreements International Journal of Circumpolar Health 72: 21351 (9 pages). [IF 1.060; PMID: 23986896]  http://www.circumpolarhealthjournal.net/index.php/ijch/article/view/21351/html
  19. Luth W, Jardine C, Bubela T. When Pictures Waste a Thousand Words: Analysis of the 2009 H1N1 Pandemic on Television News. PLoS One 8(5): e64070. [IF 4.092; PMID: 23691150]  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0064070
  20. Bubela T, Gold ER, Graff GD, Cahoy DR, Nicol D, Castle D. Patent Landscaping for Life Sciences Innovation: Toward Consistent and Transparent Practices. Nature Biotechnology 31(3): 202-206. [IF 23.268; PMID: 23471065]  http://www.nature.com/nbt/journal/v31/n3/full/nbt.2521.html
  21. Hyshka E, Bubela T, Wild C. Prospects for Scaling-Up Supervised Injection Facilities in Canada: The Role of Evidence in Legal and Political Decision-Making. Addiction 108: 468-476. [IF 4.313; PMID: 23286831]  http://onlinelibrary.wiley.com/doi/10.1111/add.12064/abstract;jsessionid=1444D115729F4E6C46328BC847644CC8.f03t02
  22. Bubela T, Yanow S. (2012) Molecular Typing: A Legal Perspective. Public Health Ethics5: 317-320.  http://phe.oxfordjournals.org/content/5/3/317.full
  23. Bubela T, Schofield PN, Ryan C, Adams R, Einhorn D. (2012) Managing Intellectual Property to Promote Pre-Competitive Research: The Mouse as a Model for Constructing a Robust Research Commons. Journal of Law, Information and Science.  http://archive-org.com/page/3815611/2014-03-08/http://www.jlisjournal.org/abstracts/Bubela_etal.22.1.html
  24. Bubela T, Li MD, Hafez M, Bieber M, Atkins H. (2012) Is Belief Larger than Fact: Expectations, optimism and reality for translational stem cell research. BMC Medicine10:133 (6 November 2012). Full Text  http://www.biomedcentral.com/1741-7015/10/133
  25. Bubela T, Reshef, A, Li MD, Atkins A, Caulfield T, Culme-Seymour E, Gold R, Illes J, Isasi R, McCabe C, Ogbogu U, Piret J, Mason C. (2012) Enhancing Advanced Cell Therapies (EnACT): Invitation to an Online Forum on Resolving Barriers to Clinical Translation. Regenerative Medicine7(6) 735-740.  http://www.futuremedicine.com/doi/abs/10.2217/rme.12.59?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov
  26. Bubela T, FitzGerald GA, Gold ER (2012) Recalibrating Intellectual Property Rights to Enhance Translational Research Collaborations. 4 Science Translational Medicine122cm3 [Impact Factor: 7.80 note that this is a new journal with statistics only from 2009. It is a AAAS journal and sister journal to Science]  http://stm.sciencemag.org/content/4/122/122cm3.full?sid=42f591b5-252b-4c95-a369-de6f3d958a2e
  27. Bubela T, Hagen G, Einsiedel E (2012) Synthetic biology confronts publics and policy makers: challenges for communication, regulation and commercialization. 30 (3) Trends in Biotechnology 132-137 [Impact Factor: 9.644]  http://www.sciencedirect.com/science/article/pii/S0167779911001806
  28. Prado M, Cristina D, Bubela T (2011) Aligning the Activities of a Technology Transfer Office with the Social Mission of a Life Sciences Research Institute in Portugal: Opportunities and Challenges for a New Office. 3(4) AUTM Technology Transfer Practice ManualOnline: http://www.autm.net/Volume_4_TOC.htm
  29. Bubela T, Gold, ER, Morin, JF (2011) Wicked Issues at the Intersection of Intellectual Property and Public Health: Mechanisms for Policy Coherence. 4 McGill Journal of Law and Health 3-42.  http://mjlh.mcgill.ca/pdfs/vol4-2/Bubela.pdf
  30. Bubela T, Morin JF (2010) Lost in Translation: The Canadian Access to Medicines Regime from Transnational Activism to Domestic Implementation. 18 Health Law Journal 113-158.http://www.ncbi.nlm.nih.gov/pubmed/22125973
  31. Rachul C, Zarzeczny A, Bubela T, Caulfield T (2010) Stem Cell Research in the News: More than a Moral Status Debate? 7 SCRIPTed – A Journal of Law, Technology & Society 311-323. http://www2.law.ed.ac.uk/ahrc/script-ed/vol7-2/rachul.asp
  32. Bubela T, Caulfield T (2010) Role and Reality: Technology Transfer at Canadian Universities. 28 Trends in Biotechnology 447-451[Impact Factor: 9.644; cited 2 times]  http://www.sciencedirect.com/science/article/pii/S0167779910000910
  33. Bubela T, Strotmann A, Noble R, Morrison S (2010) Commercialization and Collaboration: Competing Policies in Publicly-Funded Stem Cell Research? 7 Cell Stem Cell 21-30 [Impact Factor: 26.967; cited 3 times]  http://www.sciencedirect.com/science/article/pii/S1934590910002924
  34. Castle D, Phillips PWB, Brown A, Culver K, Castrataro D, Bubela T, Harmon S, Dutfield G, Barclay P (2010) Knowledge Management and the Contextualisation of Intellectual Property Rights in Innovation Systems.  7 SCRIPTed – A Journal of Law, Technology & Society 32-50.
  35. Prado M, Cristina D, Bubela T (2010) The Challenges and Opportunities in Setting up a Technology Transfer Office in a Life Sciences Research Institute in Portugal.2 Tomorrow’s Technology Transfer: The Journal of the Association of University Technology Transfer Managers 38-45.  https://www.autm.net/AM/Template.cfm?Section=Volume_4_TOC&Template=/CM/ContentDisplay.cfm&ContentID=6158
  36. Schofield PN, Bubela T, Weaver T, Brown SD, Hancock JM, Einhorn D, Tocchini-Valentini G, de Angelis MH, Rosenthal, N. (2009) Post-publication sharing of data and tools. 461 Nature 171-173 [Impact Factor: 36.104; cited 35 times]  http://www.nature.com/nature/journal/v461/n7261/full/461171a.html
  37. Bubela T, Nisbet MC, Borchelt R, Brunger F, Critchely C, Einsiedel E, Geller G, Gupta A, Hampel J, Hyde-Lay R, Jandciu EW, Jones SA, Kolopack P, Lane S, Lougheed T, Nerlich B, Ogbogu U, O’Riordan K, Ouellette C, Spear M, Strauss S, Thavaratnam T, Willemse L, Caulfield T..(2009) Science Communication Reconsidered: Challenges, Prospects, and Recommendations. 27 Nature Biotechnology 514-518  [Impact Factor: 31.090; cited 16 times].
  38. Strotmann A, Zhao D, Bubela T (2009) Author name disambiguation for collaboration network analysis and visualization. Proceedings of The American Society for Information Science and Technology 2009 Annual Meeting, November 6-11, 2009, Vancouver, British Columbia, Canada.
  39. Strotmann A, Zhao D, Bubela T (2009) A multi-database approach to field delineation. Proceedings of the International Society for Scientometrics and Informetrics, 2009 Conference, July 14-17, 2009, Rio de Janeiro, Brazil.
  40. Heaney C, Carbone J, Gold R, Bubela T, Holman CM, Cliaianni A, Lewis T, Cook-Deegan R (2009) The Perils of Taking Property Too Far. 1 Stanford Journal of Law, Science and Policy 46-64.  [PMID:20628480]             http://europepmc.org/articles/PMC2902196;jsessionid=YmBwl7TOM3a3H0wVU7u4.14
  41. Caulfield T, Zarzecsny A, McCormick J, Bubela T, Critchely C, Einsiedel, E, Galipeau J, Harmon S, Huynh M, Hyun I, Iles J, Isasi R, Joly Y, Laurie G, Lomax G, Longstaff H, McDonald M, Murdoch C, Ogbogu U, Owen-Smith J, Pattinson S, Prmji S, von Tigerstrom B, Winickoff ED. (2009) International stem cell environments: world of difference. Nature Reports Stem Cells (16 April 2009) doi:10.1038/stemcells.2009.61 Commentary.  http://www.nature.com/stemcells/2009/0904/090416/full/stemcells.2009.61.html
  42. Caulfield T, Zarzecsny A, McCormick J, Bubela T, Critchely C, Einsiedel, E, Galipeau J, Harmon S, Huynh M, Hyun I, Iles J, Isasi R, Joly Y, Laurie G, Lomax G, Longstaff H, McDonald M, Murdoch C, Ogbogu U, Owen-Smith J, Pattinson S, Prmji S, von Tigerstrom B, Winickoff ED. (2009) The Stem Cell Research Environment: A Patchwork of Patchworks. 5 Stem Cell Reviews and Reports 82-88 [cited 9 times].  http://link.springer.com/article/10.1007/s12015-009-9071-3/fulltext.html
  43. Bubela T, Boon H, Caulfield T (2008) Herbal Remedy Clinical Trials in the Media: a Comparison with the Coverage of Conventional Pharmaceuticals. 6 BMC Medicine 35 (14 pages) [Impact Factor: 5.750; cited 2 times].  http://www.biomedcentral.com/1741-7015/6/35
  44. Knowles L, Bubela T (2008) Challenges for Intellectual Property Management of HIV Vaccine-Related Research and Development: Part 1, The Global Context. 16 Health Law Journal 55-96 [cited 1 times].  http://www.ncbi.nlm.nih.gov/pubmed/19536978
  45. Patten S, Bubela T, Knowles L (2008) Challenges for Intellectual Property Management of HIV Vaccine-Related Research and Development: Part 2, The Canadian Context. 16 Health Law Journal 97-142 [cited 1 times].  http://www.ncbi.nlm.nih.gov/pubmed/19536979
  46. Caulfield T, Shelley J, Alfonso V, Bubela T (2008) Nutrigenomics and the Promise of Prevention: Representations and Realities. Health Law Journal Special Edition 41-65.  http://www.hli.ualberta.ca/HealthLawJournals/~/media/hli/Publications/HLJ/VS-04_Caulfield-Shelley-Alfonso-Bubela.pdf
  47. Caulfield T, Bubela T, Murdoch C (2007) Myriad and the Mass Media: The Covering of a Gene Patent Controversy. 9 Genetics in Medicine 850-855 [Impact Factor: 5.280; cited 12 times].  http://www.ncbi.nlm.nih.gov/pubmed/18091435
  48. Bubela T, Koper M, Boon H, Caulfield T (2007) Media portrayal of herbal remedy versus pharmaceutical clinical trials: Impacts on decision-makers. 26(2) Medicine and Law 363-373 [cited 4 times].
  49. Caulfield T, Bubela T (2007) Why a Criminal Ban?: Analyzing the Arguments Against Somatic Cell Nuclear Transfer in the Canadian Parliamentary Debate. 7(2) American Journal of Bioethics 51-61 [Impact Factor: 4.378; cited 18 times].
  50. Bubela T (2006) Science Communication in Transition: Genomics Hype, Public Engagement, Education and Commercialization Pressures. 70 Clinical Genetics 445-450 [Impact Factor: 3.273; cited 6 times].  http://onlinelibrary.wiley.com/doi/10.1111/j.1399-0004.2006.00693.x/full
  51. Bubela TM  (2004) Expert Evidence: The Ethical Responsibility of the Legal Profession. 41(4) Alberta Law Review 853-870.
  52. Bubela T, Caulfield T (2004) Do the Print Media Hype Genetic Research?: A Comparison of Newspaper Stories and Peer Reviewed Research Papers. 170(9) Canadian Medical Association Journal 1399-1407 [Impact Factor: 9.015; cited 73 times].  http://www.cmaj.ca/content/170/9/1399.long
  53. Bubela TM, Dickman CR, Newsome AE (1999)  Diet and Winter Foraging Behaviour of the Red Fox (VulpesVulpes) in Alpine and Subalpine New South Wales. 20 Australian Journal of Mammalogy 321-330.
  54. Bubela TM, Bartell R,Müller W (1998)  Factors affecting the trappability of red foxes in Kosciusko National Park: How not to be outfoxed. 25 Wildlife Research199-208 [Impact Factor: 1.279; cited 9 times].
  55. Barker J, Lunney D, Bubela T (1994).  Mammal surveys in the forests of the Carrai Plateau and Richmond Range in north-east New South Wales.  17 Australian Mammalogy19-29.
  56. Bubela TM, Happold DCD (1993)  The social organisation and mating system of an Australian subalpine rodent, the broad-toothed rat, Mastacomysfuscus Thomas. 20 Wildlife Research405-417 [Impact Factor: 1.279; cited 13 times].
  57. Bubela TM, Happold DCD, Broome LS (1991)  Home range and activity of the broad-toothed rat, Mastacomysfuscus in subalpine heathland.18 Wildlife Research 39-48 [Impact Factor: 1.279; cited 17 times].
  58. Carron PL, Happold DCD, Bubela TM (1990)  The diet of two sympatric Australian subalpine rodents, Mastacomysfuscus and Rattusfuscipes.  17 Australian Wildlife Research 479-489 [Impact Factor: 1.279; cited 23 times].

Other Journal Articles

  1. Bonter K, Bubela T(2014) Translating molecular diagnostics into the clinic. Biotechnology Focus May 28, 2014 Feature. Available online: http://biotechnologyfocus.ca/translating-molecular-diagnostics-into-the-clinic.
  2. Bubela T, Taylor B (2007) Nutrigenomics, Mass Media and Commercialization Pressures. 16(3) Health Law Review 39-47 [Special Issue on Nutrigenomics].
  3. Koper M, Bubela, T, Caulfield T, Boon H (2007) Media portrayal of conflicts of interest in biomedical research. 15 Health Law Review 30.
  4. Bubela T,  Caulfield T, Boon H (2006) Trends in Evidence-Based Medicine for Herbal Remedies and Media Coverage. 15 Health Law Review 3.
  5. DeBow S, Bubela T, Caulfield T (2006) Stem Cells, Politics and the Progress Paradigm. 15 Health Law Review 50.
  6. Fernando K, Bubela T, Caulfield T (2006) Public Trust and Regulatory Governance as represented through the Media. 15 Health Law Review 12.
  7. Koper M, Bubela T, Caulfield T, Boon H (2006) Media Portrayal of Conflicts of Interest in Herbal Remedy Clinical Trials. 15 Health Law Review 9.
  8. Caulfield T, Bubela TM (2004) Media Representations of Genetic Discoveries: Hype in the Headlines? 12(2) Health Law Review 53-61.

Letters to the Editor

  1. Paulden M, Akude P, Bubela T, McCabe C (November 1, 2013) A Canadian screening program for hepatitis C: Is now the time? CMAJ  online: http://www.cmaj.ca/content/185/15/1325/reply
  2. Bubela T, Gold R (8 December 2008) Managing intellectual property for health research and delivery. Rapid Response to : McKee, M. Global Research for Health (2008) 337 BMJ a2733 (online edition).
  3. Gold ER, Bubela T, Miller FA, Nicol D, Piper T (2007) Gene patents—more evidence needed, but policymakers must act. 25 Nature Biotechnology 388 – 389.

EDITED BOOKS

  1. Bubela T, Gold ER (eds) Genetic Resources and Traditional Knowledge: Case Studies and Conflicting Interests. (Williston, VT: Edward Elgar, 2012).

Book Chapters

  1. Bubela T, Mishra A, Mathews D. Policies and practices to enhance multi-sectorial collaborations and commercialization of regenerative medicine. In Hogle LF (ed) Regenerative Medicine Ethics: Governing Research and Knowledge Practices. (New York: Springer, 2013)
  2. Bubela T, Gold ER. Indigenous Rights and Traditional Knowledge. In Bubela T, Gold ER (eds) Genetic Resources and Traditional Knowledge: Case Studies and Conflicting Interests. (Williston, VT: Edward Elgar).
  3. Metcalf C, Bubela T. Aboriginal Rights and Traditional Ecological Knowledge in Northern Canada. In Bubela T, Gold ER (eds) Genetic Resources and Traditional Knowledge: Case Studies and Conflicting Interests. (Williston, VT: Edward Elgar).
  4. Hik DS, Bubela T, Nickels S. Respecting and Aligning Knowledge Systems in Northern Canada: Beyond the International Polar Year. In Bubela T, Gold ER (eds) Genetic Resources and Traditional Knowledge: Case Studies and Conflicting Interests. (Williston, VT: Edward Elgar).
  5. Bubela T. Grand Challenges for Evidence and Health Policy: Metrics and Indicators in Complex Systems. In Kouri R, Regis C (eds) Les grandsdéfis en droit et politiques de la santé/Grand Challenges in HealthLaw & Policy (Toronto: Thomson Reuters, 2010).
  6. Bubela T. Introduction: Innovation Governance.  Castle D (ed) The Role of Intellectual Property Rights in Biotechnology Innovation (Williston, VT: Edward Elgar Publishing, 2009).
  7. Caulfield T, Shelley J, Bubela T, Mineker L. Framing Nutrigenomics for Individual and Public Health: Public Representations and Consequences for an Emerging Field. Castle D, Ries N (eds) Nutrition and Genomics: Issues of Ethics, Law, Regulation & Communication (Amsterdam: Elsevier, 2008)223-245.
  8. Bubela T, Caulfield T. When Human Dignity is Not Enough: Embryonic Stem Cell Research and Human Cloning in Canada. In Einsiedel (ed)Emerging Technologies: Hindsight and foresight (Vancouver: UBC Press, 2008)161-184.
  9. Caulfield T and Bubela T. Popular Representations of Science, Research and Technology. In RiesN, Shelley J (eds)Food, Health and Biotechnology: Consumer and Social Issues in Canada’s New Food and Health Products Industries (Advanced Food and Materials Network, 2007) 24-28.
  10. Caulfield T,Bubela T. The Popular Media, Public Perceptions and Biotechnology Policy. In Stranger M (ed) Human Biotechnology and Public Trust: Trends, Perceptions and Regulation (Hobart: Centre for Law and Genetics, 2007) (Peer Reviewed Book Chapter)88-101.
  11. Gold ER, Bubela T. Contracting to Manage Intellectual Property: Collaborative Research Agreements and other Contracts. In Krattiger A, et al (eds) IP Management in Health and Agricultural Innovation-A Handbook of Best Practices (Oxford: MIHR, PIPRA, 2007) 725-738. This project was funded by the Rockefeller Foundation. The Handbook is primarily aimed at public sector institutions in developing countries (senior policy makers, university presidents and other heads of R&D institutions, technology transfer and licensing officers, and scientists). It is an effort to produce a most complete and authoritative resource in health and agricultural IP management as a basis of elevating the awareness and expertise in licensing transactions related to health and agriculture, particularly vis-a-vis serving the closely tied objectives of economic development.
  12. Bubela T, Durell KL. Intellectual Property and Biotechnology. In Gad, SC(ed) Handbookof Pharmaceutical Biotechnology (Cary NC: John Wiley & Sons, 2007)1391-1432.
  13. Bubela T, Caulfield T. Media Representations of Genetic Research. Einsiedel EF, Timmermans F (eds) Crossing Over. Genomics in the Public Arena (Calgary, AB, Canada: University of Calgary Press, 2005).

Working Drafts

  1. Benjaminy S, Jardine C, Bubela T. Therapeutic innovations and hyped promulgations: A critical analysis of genetic risk communication in light of gene therapy trials. Health Risk and Society.
  2. Geary J, Jardine C, Bubela T. Attribution theory and risks associated with sharing genetic resources. For submission to a risk communication journal.
  3. Geary J, O’Byrne S, Bubela T. Relational Contract Theory and North-South Research Partnerships. For submission to a law journal.
  4. Guebert J, Gislason K, Bubela T. The Legal and Regulatory Obstacles of Semi-Synthetic Opiates from Engineered Yeast. For submission  to a law journal.
  5. Guebert J, Zylstra A, Bubela T. Health Research in Publicly Funded Institutions: Ethics and Public Goods over Economics and Private Interests. For submission to The Lancet.
  6. Bubela T, Ryan C, Strotmann A, Noble R, Orton N, Liu S, Morrison S, Einsiedel E. Governing the Mouse Commons: An Institutional Analysis Framework. For submission to the Yale Journal of Health Policy, Law, and Ethics (in preparation).
  7. Noble R, Bubela T, Ryan C Canada’s contribution to the global mouse research commons. Manuscript solicited by McGill Journal of Law and Health.